Company profile for Mirus Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Mirus Bio LLC is a life science company focused on discovering, developing and commercializing innovative nucleic acid based technologies and products. Mirus R&D uniquely integrates nucleic acid delivery and chemistry, a core competency which is unmatched in the industry. This serves as the foundation for its novel research reagents. Mirus is a recognized leader in developing innovative nucleic acid research reagents, distin...
Mirus Bio LLC is a life science company focused on discovering, developing and commercializing innovative nucleic acid based technologies and products. Mirus R&D uniquely integrates nucleic acid delivery and chemistry, a core competency which is unmatched in the industry. This serves as the foundation for its novel research reagents. Mirus is a recognized leader in developing innovative nucleic acid research reagents, distinguished by its many accomplishments.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
5602 Research Park Blvd, Ste 210, Madison, WI 53719
Telephone
Telephone
6084412849
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.reuters.com/business/healthcare-pharmaceuticals/merck-lowers-mid-term-healthcare-outlook-after-recent-drug-failures-2024-10-17/

REUTERS
16 Oct 2024

https://www.contractpharma.com/contents/view_breaking-news/2024-08-01/milliporesigma-closes-acquisition-of-mirus-bio/?widget=listSection

CONTRACT PHARMA
01 Aug 2024

https://www.merckgroup.com/en/news/definite-agreement-mirus-bio-22-05-2024.html

PRESS RELEASE
23 May 2024

https://www.sigmaaldrich.com/IN/en/collections/press/agreement-to-acquire-mirus-bio

PRESS RELEASE
22 May 2024

https://www.prnewswire.com/news-releases/mirus-bio-launches-revit-aav-enhancer-301893156.html

PR NEWSWIRE
03 Aug 2023

ABOUT THIS PAGE

Contact Mirus Bio and get a quotation

Mirus Bio is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of TRANSIT-VIRUSGEN GMP TRANSFECTION REAGENT bulk with DMF offered by Mirus Bio

Find a price of REVIT GMP AAV ENHANCER bulk with DMF offered by Mirus Bio

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty